Cefuroxime Injection, Powder, For Solution
Product Images NDC 0143-9569

4 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cefuroxime (NDC 0143-9569). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Cefuroxime For Injection Pbp Novaplus 1)

Chemical Structure (Cefuroxime For Injection Pbp Novaplus 1)
Chemical structure of Cefuroxime, showing the molecular configuration including key chemical groups and bonds characteristic to the active ingredient in the product.*
FDA Label Image

Ndc 0143-9569-01 Rx Only Cefuroxime For Injection, Usp Pharmacy Bulk Package Not For Direct Infusion For Intravenous Use Only 7.5 G/vial Not To Be Dispensed As A Unit After Constitution Further Dilution Is Required Prior To Use. This Package Is Not Intended To Be Dispensed As A Unit. This Is A Pharmacy Bulk Package Which Contains Many Single Doses For Use In A Pharmacy Admixture Program. See Package Insert For Proper Use. Each Pharmacy Bulk Package Vial Contains Sterile Cefuroxime Sodium Equivalent To Cefuroxime 7.5 G. Cefuroxime For Injection Contains Approximately 54.2 mg (2.4 Meq) Of Sodium Per Gram Of Cefuroxime Activity. Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Controlled Room Temperature]. Protect From Light. Constitution: Penetrate One Time Using A Sterile Dispensing Device. Add 77 mL Of Sterile Water For Injection. Shake Well To Dissolve. The Constituted Solution Occupies A Volume Of About 82.5 mL And Contains Approximately 750 mg Of Cefuroxime Per 8 mL. Not For Direct Infusion. Dispense Aliquots From The Vial Via A Suitable Dispensing Device Into Infusion Fluids Under A Laminar Flow Hood Using Aseptic Technique. Withdraw Contents Without Delay. Discard Vials 4 Hours After Initial Entry. Color Changes In Solution Do Not Affect Potency. Date And Time Of Entry:_______/________ (Cefuroxime For Injection Pbp Novaplus 2)

Ndc 0143-9569-01 Rx Only Cefuroxime For Injection, Usp Pharmacy Bulk Package Not For Direct Infusion For Intravenous Use Only 7.5 G/vial Not To Be Dispensed As A Unit After Constitution Further Dilution Is Required Prior To Use. This Package Is Not Intended To Be Dispensed As A Unit. This Is A Pharmacy Bulk Package Which Contains Many Single Doses For Use In A Pharmacy Admixture Program. See Package Insert For Proper Use. Each Pharmacy Bulk Package Vial Contains Sterile Cefuroxime Sodium Equivalent To Cefuroxime 7.5 G. Cefuroxime For Injection Contains Approximately 54.2 mg (2.4 Meq) Of Sodium Per Gram Of Cefuroxime Activity. Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Controlled Room Temperature]. Protect From Light. Constitution: Penetrate One Time Using A Sterile Dispensing Device. Add 77 mL Of Sterile Water For Injection. Shake Well To Dissolve. The Constituted Solution Occupies A Volume Of About 82.5 mL And Contains Approximately 750 mg Of Cefuroxime Per 8 mL. Not For Direct Infusion. Dispense Aliquots From The Vial Via A Suitable Dispensing Device Into Infusion Fluids Under A Laminar Flow Hood Using Aseptic Technique. Withdraw Contents Without Delay. Discard Vials 4 Hours After Initial Entry. Color Changes In Solution Do Not Affect Potency. Date And Time Of Entry:_______/________ (Cefuroxime For Injection Pbp Novaplus 2)
Cefuroxime 7.5 g per vial injection powder for solution, USP, for intravenous use only. The label indicates this is a pharmacy bulk package not for direct infusion or dispensing as a unit. Manufactured by Hikma Pharmaceuticals USA Inc. It includes directions for constitution and storage conditions as well as warnings about proper use and disposal.*
FDA Label Image

Ndc 0143-9569-10 Rx Only Cefuroxime For Injection, Usp Pharmacy Bulk Package (NOT FOR DIRECT INFUSION FOR INTRAVENOUS USE ONLY 7.5 g/vial AFTER CONSTITUTION FURTHER DILUTION IS REQUIRED PRIOR TO USE THIS PACKAGE IS NOT INTENDED TO BE DISPENSED AS A UNIT PROTECT FROM LIGHT)

Ndc 0143-9569-10 Rx Only Cefuroxime For Injection, Usp Pharmacy Bulk Package (NOT FOR DIRECT INFUSION FOR INTRAVENOUS USE ONLY 7.5 g/vial AFTER CONSTITUTION FURTHER DILUTION IS REQUIRED PRIOR TO USE THIS PACKAGE IS NOT INTENDED TO BE DISPENSED AS A UNIT PROTECT FROM LIGHT)
Cefuroxime for injection, USP, 7.5 g per vial, powder for solution for intravenous use only. The label indicates this is a pharmacy bulk package not for direct infusion, containing 10 vials. It is manufactured by Hikma Pharmaceuticals USA Inc. and sold under the Novaplus brand. The NDC number is 0143-9569-10.*
FDA Label Image

Ndc 0143-9569-10 Rx Only Cefuroxime For Injection, Usp Pharmacy Bulk Package (NOT FOR DIRECT INFUSION FOR INTRAVENOUS USE ONLY 7.5 g/vial AFTER CONSTITUTION FURTHER DILUTION IS REQUIRED PRIOR TO USE THIS PACKAGE IS NOT INTENDED TO BE DISPENSED AS A UNIT PROTECT FROM LIGHT)

Ndc 0143-9569-10 Rx Only Cefuroxime For Injection, Usp Pharmacy Bulk Package (NOT FOR DIRECT INFUSION FOR INTRAVENOUS USE ONLY 7.5 g/vial AFTER CONSTITUTION FURTHER DILUTION IS REQUIRED PRIOR TO USE THIS PACKAGE IS NOT INTENDED TO BE DISPENSED AS A UNIT PROTECT FROM LIGHT)
Cefuroxime injection powder for solution label snippet showing a QR code and text fields for GTIN, serial number, expiration date, and lot number. The label includes placeholder alphanumeric codes and dates, indicating product traceability features. Labeler is Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.